E-MAIL UPDATES

Click here to join

At the cutting edge

At the
cutting edge.

Research for life

Research
for life.

Innovation and performance

Innovation and
performance.

Latest

What's new.

For a copy of this analyst report please contact your CLSA advisor

November 29th 2022
analyst reports

For a copy of this analyst report please contact your Petra advisor

November 29th 2022
analyst reports

November 29th 2022
analyst reports

November 29th 2022
press releases

November 17th 2022
investor updates

For a copy of this analyst report please contact your Petra advisor

November 16th 2022
analyst reports
more

Upcoming Events

What's next.

December 6th 2022 - December 7th 2022

read more
January 9th 2023 - January 12th 2023

read more

Who we are

About us.

passion.

It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.

know-how.

Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.

research.

Accurate research and development is the strongest foundation for developing effective treatments.

What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG-3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.